Kazia Therapeutics - ADR Peer Comparison

$12.31

$0.15 (1.23%)

As on 04-Sep-2026 16:00EDT

Market cap

$141 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

5.7

Div. Yield

0 %

Edit

	Kazia Therapeutics - ADR	Alterity Therapeutics - ADR	Immutep - ADR	Immuron - ADR (IMRN)
Market cap ($ Mln)	141	83	54	15
Revenue (A$ Mln)	0	--	14	8
Net Profit (A$ Mln)	-20.70	-22.89	-77.57	-3.75
Net Margin (%)	-2,284,277.09	-531.34	-1,030.32	-71.92
RoE (%)	226.03	-53.78	-75.62	-39.44
Price to Earnings	--	--	--	--
Price-To-Book	5.69	2.71	1.22	1.10

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (A$ Mln)

	Kazia Therapeutics - ADR	Alterity Therapeutics - ADR	Immutep - ADR	Immuron - ADR (IMRN)
Operating Revenue	0.04	5.44	5.04	7.29
Cost of Revenue	--	0.13	61.41	2.52
Gross Profit	0.04	5.31	-56.37	4.77
Operating Expenses	14.26	19.89	70.06	10.11
Operating Profit (EBIT)	-14.22	-14.57	-126.42	-5.34
Other Income	--	--	--	--
Profit before Tax	-22.45	-12.08	-61.43	-5.22
Provision for Tax	-1.75	0.07	--	--
Profit after Tax (Net Income)	-20.70	-12.15	-61.43	-5.22
Minority Interest	--	--	--	--
Consolidated Profit	--	--	--	--

Liabilities (A$ Mln)

	Kazia Therapeutics - ADR	Alterity Therapeutics - ADR	Immutep - ADR	Immuron - ADR (IMRN)
Shareholder's Funds	-8.30	42.40	143.64	8.03
Minority Interest	--	--	--	--
Non-Current Liabilities	0.31	0.09	0.59	0.09
Current Liabilities	14.05	3.53	12.76	1.97
Total Liabilities	6.06	46.03	156.98	10.09

Assets (A$ Mln)

	Kazia Therapeutics - ADR	Alterity Therapeutics - ADR	Immutep - ADR	Immuron - ADR (IMRN)
Non-Current Assets	1.13	0.16	7.89	0.11
Current Assets	4.93	45.87	149.10	9.98
Total Assets	6.06	46.03	156.98	10.09
Total Debt*	0.40	0.16	1.63	0.12
Net Current Assets	-9.12	42.34	--	8.05

Cashflow (A$ Mln)

	Kazia Therapeutics - ADR	Alterity Therapeutics - ADR	Immutep - ADR	Immuron - ADR (IMRN)
Cash From Operating Activities	-13.28	-11.45	-62.05	-6.14
Cash Flow from Investing Activities	--	-7.50	-38.53	-2.90
Cash from Financing Activities	15.98	39.67	-0.53	0.20
Net Cash Inflow / Outflow	--	--	--	--

Ratios

Profitability Ratios

	Kazia Therapeutics - ADR	Alterity Therapeutics - ADR	Immutep - ADR	Immuron - ADR (IMRN)
ROCE (%)	239.50	-42.99	-36.53	-49.60
ROE (%)	226.03	-43.23	-36.88	-50.30
ROA (%)	-149.76	-37.23	-34.27	-40.68
EBIT Margin (%)	--	--	--	--
Net Margin (%)	-49,290.48	-223.35	-1,218.02	-71.58
Cash Profit Margin (%)	--	--	--	--

Growth Ratios

	Kazia Therapeutics - ADR	Alterity Therapeutics - ADR	Immutep - ADR	Immuron - ADR (IMRN)
Revenue Growth (%)	-0.98	0.35	0.31	0.49
EBIT Growth (%)	--	--	--	--
Net Profit Growth (%)	22.69	36.48	-43.82	24.81
EPS Growth (%)	0.56	0.46	-0.20	0.27
Book Value Growth (%)	--	--	--	--

Valuation Ratios

	Kazia Therapeutics - ADR	Alterity Therapeutics - ADR	Immutep - ADR	Immuron - ADR (IMRN)
Price / Earnings	-0.26	-4.20	-3.89	-1.95
Price / Book Value	-0.64	1.20	1.67	1.27
Dividend Yield (%)	--	--	--	--
EV/EBITDA	-0.10	-0.72	-1.77	-0.84
Market Cap ($ Cr)	--	--	--	--

Solvency Ratios

	Kazia Therapeutics - ADR	Alterity Therapeutics - ADR	Immutep - ADR	Immuron - ADR (IMRN)
Debt to Equity	-0.05	0.00	0.01	0.01
Short term debt to equity ratio	-0.05	0.00	0.01	0.01
Current Ratio	0.35	12.98	11.69	5.07
Quick Ratio	--	--	--	4.17
Interest Coverage	--	--	-2,707.45	-733.30

Operating Efficiency Ratios

	Kazia Therapeutics - ADR	Alterity Therapeutics - ADR	Immutep - ADR	Immuron - ADR (IMRN)
Debtors to sales (%)	214.29	72.40	0.15	10.86
Asset Turnover	0.00	0.17	0.03	0.57
Receivable days	969.65	267.92	273.95	54.61
Inventory Days	--	-64.13	11.33	243.10
Payable days	--	1,603.11	27.73	157.74
Cash Conversion Cycle	--	-1,399.31	257.55	139.96

Annual
Quarterly